瓦莱瑞姆推出高收益的代币化黄金;Poolbeg Pharma获得癌症治疗专利. Valereum launches tokenized gold with high yields; Poolbeg Pharma wins patent for cancer treatment.

瓦莱里安推出VGOLD,一种代币化黄金产品,为投资代币提供10%至15%的收益率. Valereum has launched VGOLD, a tokenized gold product offering a 10% to 15% yield for staking tokens for over a year. 公司计划在美国上市,因为它正在扩大其数字资产基础设施. The company plans a potential U.S. listing as it expands its digital asset infrastructure. 尔贝格制药公司获得了首个国家专利,用于治疗癌症免疫疗法的严重副作用. Poolbeg Pharma secured its first national patent for POLB-001, a treatment for a serious side effect of cancer immunotherapy.